Miromatrix Medical Inc. develops technology for creating fully transplantable organs using a two-step method of decellularization and recellularization. The technology replaces pig cells with unmodified human cells, making the organs fully compatible with human recipients. Collaborations with renowned medical institutions like The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute enhance the company's research and development.